1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)
- 2004
- Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer
- 2002
- Physical performance, toxicity, and quality of life as assessed by the physician and the patient